ArticlePharmacoEconomics2026
Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.
Article in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionDose administration aids (DAAs) support medication taking, yet little is known about how pharmacists perceive DAA benefits and challenges. This study aimed to explore community pharmacists' preferences for attributes of a DAA service and how these influence their decision to provide this service.
methodsA discrete choice experiment (DCE) was conducted to elicit pharmacists' preferences. Participants completed 12 choice questions, each presenting three alternatives: two DAA services and no DAA service. The questions included seven attributes: patient type, patient control over their medicines, impact on patient medication adherence, staff time, patient co-payment, government reimbursement fee and presence of a cap on government funded DAA services per pharmacy.
resultsA total of 615 community pharmacists completed the DCE survey. All attributes, except patient type and co-payment, significantly influenced preferences. Pharmacists were more likely to provide a DAA service (compared with no DAA service) when it was associated with higher government funding (pharmacy owners: OR 1.054, 95% CI 1.046-1.063, p < 0.001; non-owners: OR 1.041, 95% CI 1.036-1.046, p < 0.001). Pharmacists were less likely to provide a DAA service if there was a cap on the number of funded DAA services (OR 0.905, 95% CI 0.862-0.950, p < 0.001), or additional staff time was required (OR 0.981, 95% CI 0.976-0.986, p < 0.001).
conclusionThis DCE identified two key policy-related barriers to pharmacist provision of DAA services: inadequate government reimbursement and caps on the number of funded DAA services. These findings highlight community pharmacists' preferences and trade-offs, offering valuable guidance to inform future redesign and implementation of more sustainable and equitable DAA services provided via community pharmacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.